Morgan Stanley maintains Overweight on Nasdaq, lowers target to $112
Morgan Stanley analyst Michael Cyprys maintained an Overweight rating on Nasdaq but lowered the price target to $112 from $116. Separately, Raymond James analyst Patrick O'Shaughnessy maintained an Outperform rating and raised the price target to $113 from $111.

*this image is generated using AI for illustrative purposes only.
Morgan Stanley analyst Michael Cyprys has maintained an Overweight rating on Nasdaq while lowering the price target. The new target stands at $112, a decrease from the previous $116. Separately, Raymond James analyst Patrick O'Shaughnessy has maintained an Outperform rating on Nasdaq while raising the price target to $113 from $111.
Rating and Price Action
The rating affirmation and price target adjustments reflect the analysts' updated outlooks on the stock. The revised targets suggest varying potential upsides based on current market prices.
| Metric | Morgan Stanley | Raymond James |
|---|---|---|
| Rating | Overweight | Outperform |
| Previous Price Target | $116 | $111 |
| New Price Target | $112 | $113 |
What factors are driving the divergent price target adjustments between Morgan Stanley and Raymond James?
How might Nasdaq's recent performance influence future analyst ratings and price targets?
What impact could these revised price targets have on investor sentiment and trading volume?

































